Kerry Wentworth - Aug 29, 2022 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief Regulatory Officer
Signature
Kerry Wentworth, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/31/2022, 05:18 PM
Previous filing
May 25, 2022
Next filing
Mar 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +252K $0.00 252K Aug 29, 2022 Class A Common Stock 252K $2.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date